Company linked to meningitis cases paid execs more than $20M last year

The Massachusetts pharmaceutical company linked to a fungal meningitis outbreak that caused 44 deaths has reported nearly $21.2 million in both salaries to key executives and credit card reimbursements since December 2011.

This article requires free registration

This article requires free registration to The National Law Journal. Please sign in or register to read the full text.